The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...

U.S. officials are warning about a potentially life-threatening issue with smartphone apps that help manage diabetes.

Glucotrack has cleared the first human clinical study of its long-term continuous glucose monitoring implant, designed to ...

Diabetes device expert Steph Habif said her family's experiment with CGMs shows a big opportunity for wearables: intermittent ...

The use of a continuous glucose monitor during pregnancy may be more cost-effective than self-monitoring blood glucose for ...

One cupcake won't kill you,' 'I'm going to get diabetes just looking at that,' 'That person doesn't look like they have ...

The company’s system is placed in the subclavian vein, a blood vessel that runs under the collar bone bringing deoxygenated ...

Discover how the first FDA-approved over-the-counter continuous glucose monitor affects the wellness industry and its potential for early diabetes diagnoses.

Abbott (NYSE:ABT) today unveiled a new initiative addressing the biases and stigmas associated with diabetes management.

When you buy through our links, we may earn a commission. Learn more› By Dave Gershgorn Dave Gershgorn is a writer covering monitors, laptops, and tablets. He is a certified display calibrator ...

Beta Bionics has begun life as a public company with a $204m initial public offering (IPO), significantly higher than its anticipated target. The US-based company sold 12 million shares of its common ...